Markets:

Overview

News

Currencies

International

Treasuries

Humacyte, Inc. - Common Stock (NQ:HUMA)

1.060 +0.090 (+9.28%)

Streaming Delayed Price Updated: 3:36 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Humacyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Humacyte, Inc. (HUMA)

October 19, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Humacyte, Inc. (HUMA)

October 19, 2024

NEW YORK, NY - (NewMediaWire) - October 19, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQ: HUMA).

Via TheNewswire.com

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 17, 2024

Via Benzinga

How Is The Market Feeling About Humacyte? ↗

September 05, 2024

Via Benzinga

How Is The Market Feeling About Humacyte? ↗

August 19, 2024

Via Benzinga

HUMA Stock Earnings: Humacyte Misses EPS for Q2 2024 ↗

August 13, 2024

HUMA stock results show that Humacyte missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Unpacking the Latest Options Trading Trends in Humacyte ↗

August 12, 2024

Via Benzinga

(HUMA) - Analyzing Humacyte's Short Interest ↗

July 15, 2024

Via Benzinga

Peering Into Humacyte's Recent Short Interest ↗

June 26, 2024

Via Benzinga

Delay Hits Humacyte's Bioengineered Human Tissue Implant For Vascular Trauma Injuries, FDA Extends Time To Review ↗

August 12, 2024

FDA extends review timeline for Humacyte's FDA marketing application for its acellular tissue-engineered vessel in vascular trauma. Originally set for August 2024, the new action date remains...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

August 12, 2024

It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!

Via InvestorPlace

Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket ↗

August 12, 2024

Via Benzinga

8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803% ↗

August 01, 2024

Macro environment favors large-caps, but July saw impressive gains for small-caps, with Serve Robotics leading at 803% and Q32 Bio at 101%.

Via Benzinga

How Is The Market Feeling About Humacyte? ↗

June 07, 2024

Via Benzinga

Peering Into Humacyte's Recent Short Interest ↗

May 10, 2024

Via Benzinga

Three Small-Cap Stocks to Buy Before a September-Rate-Cut Rally ↗

July 18, 2024

Discover three small-cap stocks to buy before the Fed acts on interest rates as these small-cap stocks will utilize any cuts to multiply.

Via InvestorPlace

Topics Economy

What's Going On With Huamacyte Shares Tuesday? ↗

July 16, 2024

Humacyte has so far added Dr. John P. Bamforth and Dr. Keith Anthony to its Board of Directors, entered a license agreement with Pluristyx and received Regenerative Medicine Advanced Therapy (RMAT)...

Via Benzinga

Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 15, 2024

Via Benzinga

MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday ↗

July 15, 2024

Via Benzinga

Pluristyx Announces License Agreement with Humacyte to Develop BioVascular Pancreas using iPSCs

July 09, 2024

From Pluristyx

Via Business Wire

Why Humacyte Stock Is Trading 15% Higher Monday ↗

July 01, 2024

Humacyte received the Food and Drug Administration's Regenerative Medicine Advanced Therapy designation for its Acellular Tissue Engineered Vessel.

Via Benzinga

Tommy Tuberville Sells Several Large Stock Positions, Makes New Buys: Here's What The US Senator Is Betting On Now ↗

June 17, 2024

Senator Tommy Tuberville disclosed numerous stock trades on Friday June 14. A look at some of the key highlights.

Via Benzinga

AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

June 17, 2024

Via Benzinga

Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 31, 2024

Via Benzinga

Why American Eagle Outfitters Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 30, 2024

Via Benzinga

HUMA Stock Earnings: Humacyte Misses EPS for Q1 2024 ↗

May 10, 2024

HUMA stock results show that Humacyte missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 19, 2024

Via Benzinga

Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday ↗

April 19, 2024

Via Benzinga

Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday ↗

April 18, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.